Risedronate Sodium

Especificaciones

115436-72-1Número CAS

601-362-8Número CE

sodium hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinateNombre IUPAC

C7H10NNaO7P2Fórmula química

305.09 g/molPeso molecular

Risedronate sodium; 115436-72-1; Actonel; Atelvia; Risedronate monosodium; Risedronic acid monosodium salt; OFG5EXG60L; risedronate sodium anhydrous; NE-58095 ANHYDROUS; NSC-722598; NSC-759280; Monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate; Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, monosodium salt; DTXCID9026132; NSC722598; Risendronate Sodium; RefChem:930781; Risedronate sodium hemi-pentahydrate; risedronate sodium monohydrate; 658-043-1; DTXSID1046132; Sodium risedronate; Risedronic acid sodium salt; RISEDRONIC ACID SODIUM; NE 58095; Risedronate (sodium); MFCD01706268; NE-58095; Benet; Sodium trihydrogen (1-hydroxy-2-(3-pyridyl)ethylidene)diphosphonate; Actonel (TN); (1-Hydroxy-2-(pyridin-3-yl)ethane-1,1-diyl)bis(phosphonic acid) sodium salt; sodium hydrogen (1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate; Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1); sodium hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate; Sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate; sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate; Risedronate sodium [USAN]; C7H10NNaO7P2; Risedronate D4 13C (M+5) sodium salt; 122458-82-6; UNII-OFG5EXG60L; Optinate; Acrel; Sodium trihydrogen [1-hydroxy-2-(3-pyridyl)ethylidene]diphosphonate; Risedronate sodium [USAN:USP]; Optinate Septimum; 115436-72-1 (sodium); Monosodium Risedronate; Risedronate sodium (USP); CHEMBL1654; SCHEMBL18377; orb320453; Risedronate sodium, min 97%; CHEBI:8868; orb1309966; SCHEMBL29380338; DTXSID20924178; DRFDPXKCEWYIAW-UHFFFAOYSA-M; RISEDRONATE SODIUM [VANDF]; RISEDRONATE SODIUM [MART.]; HY-B0119; RISEDRONATE SODIUM [USP-RS]; RISEDRONATE SODIUM [WHO-DD]; AC-732; Risedronate Sodium 2.5-Hydrate CRS; s1428; sodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate; [1-Hydroxy-2-(3-pyridinyl)ethylidene]bisphosphonic Acid Monosodium Salt; AKOS015833432; AB09807; CCG-213235; CS-1883; NSC 722598; NSC 759280; RISEDRONATE SODIUM [ORANGE BOOK]; NCGC00346521-01; AC-20120; AS-13309; RISEDRONATE SODIUM [USP MONOGRAPH]; M2289; RISEDRONIC ACID MONOSODIUM SALT [MI]; D00942; H11438; AB01274790-01; F556522; Q27285633; 2-(3-Pyridinyl)-2-hydroxyethylidene-1,1-bisphosphonate; Monosodium 1-Hydroxy-2-(3-pyridyl)ethylidene-1,1-diphosphonate; monosodium(1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate; 1-hydroxy-2-(3-pyridinyl) ethylidene bis-phosphonic acid monosodium salt; Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, disodium salt; Phosphonic acid, (2-hydroxy-2-(3-pyridinyl)ethylidene)bis-, disodium salt; Risedronate sodium, United States Pharmacopeia (USP) Reference Standard; sodium;hydroxy-[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphinate; Risedronate sodium 2.5-hydrate, European Pharmacopoeia (EP) Reference Standard; Risedronate Sodium, Pharmaceutical Secondary Standard; Certified Reference Material; 2673270-23-8; Anhydrous Risedronate Sodium; Risédronate monosodique anhydreSinónimos